These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 11034201

  • 1. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins.
    Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A.
    Nature; 2000 Oct 05; 407(6804):592-8. PubMed ID: 11034201
    [Abstract] [Full Text] [Related]

  • 2. Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma.
    Lasorella A, Boldrini R, Dominici C, Donfrancesco A, Yokota Y, Inserra A, Iavarone A.
    Cancer Res; 2002 Jan 01; 62(1):301-6. PubMed ID: 11782392
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
    Fukuma M, Okita H, Hata J, Umezawa A.
    Oncogene; 2003 Jan 09; 22(1):1-9. PubMed ID: 12527902
    [Abstract] [Full Text] [Related]

  • 8. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
    Cotta CV, Leventaki V, Atsaves V, Vidaki A, Schlette E, Jones D, Medeiros LJ, Rassidakis GZ.
    Cancer; 2008 Feb 01; 112(3):552-61. PubMed ID: 18085637
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice.
    Lasorella A, Rothschild G, Yokota Y, Russell RG, Iavarone A.
    Mol Cell Biol; 2005 May 01; 25(9):3563-74. PubMed ID: 15831462
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product.
    Rustgi AK, Dyson N, Bernards R.
    Nature; 1991 Aug 08; 352(6335):541-4. PubMed ID: 1865909
    [Abstract] [Full Text] [Related]

  • 16. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
    Alvaro-Blanco J, Martínez-Gac L, Calonge E, Rodríguez-Martínez M, Molina-Privado I, Redondo JM, Alcamí J, Flemington EK, Campanero MR.
    Carcinogenesis; 2009 Mar 08; 30(3):440-8. PubMed ID: 19126644
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.